Bausch Health
228 hedge funds and large institutions have $1.27B invested in Bausch Health in 2026 Q1 according to their latest regulatory filings, with 30 funds opening new positions, 84 increasing their positions, 59 reducing their positions, and 34 closing their positions.
42% more repeat investments, than reductions
Existing positions increased: 84 | Existing positions reduced: 59
0% more funds holding in top 10
Funds holding in top 10: 4 → 4 (0)
1.1% less ownership
Funds ownership: 63.63% → 62.53% (-1.1%)
3% less funds holding
Funds holding: 236 → 228 (-8)
12% less first-time investments, than exits
New positions opened: 30 | Existing positions closed: 34
23% less capital invested
Capital invested by funds: $1.64B → $1.27B (-$377M)
36% less call options, than puts
Call options by funds: $15.3M | Put options by funds: $23.9M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Nuveen
Charlotte,
North Carolina
|
+$20.7M |
| 2 |
Acadian Asset Management
Boston,
Massachusetts
|
+$16M |
| 3 |
Geode Capital Management
Boston,
Massachusetts
|
+$15M |
| 4 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
+$13.5M |
| 5 |
GJL
Gendell Jeffrey L
|
+$10M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
National Bank of Canada
Montreal,
Quebec, Canada
|
-$29.5M |
| 2 |
Arrowstreet Capital
Boston,
Massachusetts
|
-$9.15M |
| 3 |
OCM
Oaktree Capital Management
Los Angeles,
California
|
-$8.83M |
| 4 |
Millennium Management
New York
|
-$8.37M |
| 5 |
D.E. Shaw & Co
New York
|
-$6.34M |
BHC Hedge Fund Activity: Q1 2026 in Review
228 of the 8,190 institutional investors tracked by Wall St. Rank reported a position in Bausch Health (BHC) for Q1 2026, worth a combined $1.27B — down 23% from $1.64B a quarter earlier.
Sellers outnumbered buyers: 34 funds closed out of BHC and 30 opened new positions — a net loss of 4 holders — while 59 trimmed existing stakes and 84 added.
The largest buyer was Nuveen, adding an estimated $20.7M. The largest seller was National Bank of Canada, cutting an estimated $29.5M.
- 228 institutional investors held Bausch Health (BHC) as of Q1 2026, down from 236 in Q4 2025.
- Funds reported $1.27B of Bausch Health stock for Q1 2026, down 23% quarter-over-quarter.
- 30 funds opened new Bausch Health positions in Q1 2026 and 34 closed out, a net change of -4 holders.
- The largest Bausch Health buyer in Q1 2026 was Nuveen, an estimated $20.7M added.
- The largest Bausch Health seller in Q1 2026 was National Bank of Canada, an estimated $29.5M sold.
Based on aggregated 13F filings for Q1 2026.